Arlene R. Collins

1.1k total citations
15 papers, 876 citations indexed

About

Arlene R. Collins is a scholar working on Infectious Diseases, Animal Science and Zoology and Oncology. According to data from OpenAlex, Arlene R. Collins has authored 15 papers receiving a total of 876 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 11 papers in Animal Science and Zoology and 3 papers in Oncology. Recurrent topics in Arlene R. Collins's work include Animal Virus Infections Studies (11 papers), SARS-CoV-2 and COVID-19 Research (9 papers) and Viral gastroenteritis research and epidemiology (5 papers). Arlene R. Collins is often cited by papers focused on Animal Virus Infections Studies (11 papers), SARS-CoV-2 and COVID-19 Research (9 papers) and Viral gastroenteritis research and epidemiology (5 papers). Arlene R. Collins collaborates with scholars based in United States and Canada. Arlene R. Collins's co-authors include Robert L. Knobler, Michael J. Buchmeier, Harry Powell, Supriya D. Mahajan, E. Ann Yeh, Michael E. Cohen, Patricia K. Duffner, Howard Faden, Ole Gade Sørensen and Thomas D. Flanagan and has published in prestigious journals such as PEDIATRICS, Virology and Advances in experimental medicine and biology.

In The Last Decade

Arlene R. Collins

15 papers receiving 855 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arlene R. Collins United States 10 643 311 263 101 99 15 876
Caitlin E. Edwards United States 11 859 1.3× 158 0.5× 226 0.9× 172 1.7× 226 2.3× 17 1.3k
Lok-Yin Roy Wong United States 13 579 0.9× 104 0.3× 169 0.6× 215 2.1× 177 1.8× 24 818
John Chi Wang Ho Hong Kong 10 690 1.1× 40 0.1× 190 0.7× 93 0.9× 306 3.1× 17 1.2k
Kendra L. Gully United States 8 800 1.2× 160 0.5× 211 0.8× 138 1.4× 148 1.5× 12 991
B. L. DeVald United States 8 169 0.3× 103 0.3× 72 0.3× 102 1.0× 43 0.4× 12 387
Zhe Zhu China 12 298 0.5× 33 0.1× 162 0.6× 31 0.3× 110 1.1× 28 597
Liis Haljasmägi Estonia 8 470 0.7× 74 0.2× 73 0.3× 120 1.2× 79 0.8× 13 601
Alan Sariol United States 9 473 0.7× 38 0.1× 147 0.6× 206 2.0× 112 1.1× 20 749
Edoardo Schneider Italy 7 443 0.7× 62 0.2× 123 0.5× 80 0.8× 149 1.5× 8 617
Carmon Kee Germany 8 406 0.6× 30 0.1× 109 0.4× 139 1.4× 146 1.5× 16 593

Countries citing papers authored by Arlene R. Collins

Since Specialization
Citations

This map shows the geographic impact of Arlene R. Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arlene R. Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arlene R. Collins more than expected).

Fields of papers citing papers by Arlene R. Collins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arlene R. Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arlene R. Collins. The network helps show where Arlene R. Collins may publish in the future.

Co-authorship network of co-authors of Arlene R. Collins

This figure shows the co-authorship network connecting the top 25 collaborators of Arlene R. Collins. A scholar is included among the top collaborators of Arlene R. Collins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arlene R. Collins. Arlene R. Collins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Mahajan, Supriya D., et al.. (2009). SARS coronavirus spike protein-induced innate immune response occurs via activation of the NF-κB pathway in human monocyte macrophages in vitro. Virus Research. 142(1-2). 19–27. 187 indexed citations
2.
Yeh, E. Ann, Arlene R. Collins, Michael E. Cohen, Patricia K. Duffner, & Howard Faden. (2004). Detection of Coronavirus in the Central Nervous System of a Child With Acute Disseminated Encephalomyelitis. PEDIATRICS. 113(1). e73–e76. 234 indexed citations
3.
Collins, Arlene R.. (2002). In Vitro Detection of Apoptosis in Monocytes/Macrophages Infected with Human Coronavirus. Clinical and Vaccine Immunology. 9(6). 1392–1395. 59 indexed citations
4.
Collins, Arlene R.. (2001). Induction of Apoptosis in MRC-5, Diploid Human Fetal Lung Cells after Infection with Human Coronavirus OC43. Advances in experimental medicine and biology. 494. 677–682. 9 indexed citations
5.
Collins, Arlene R.. (1998). Human Macrophages are Susceptible to Coronavirus OC43. Advances in experimental medicine and biology. 440. 635–639. 14 indexed citations
6.
Collins, Arlene R.. (1996). Fields Virology. Immunological Investigations. 25(4). 383–384. 1 indexed citations
7.
Collins, Arlene R.. (1995). Identification of 120 kD and 30 kD Receptors for Human Coronavirus OC43 in Cell Membrane Preparations from Newborn Mouse Brain. Advances in experimental medicine and biology. 380. 387–390. 1 indexed citations
8.
Collins, Arlene R.. (1995). Interferon γ Potentiates Human Coronavirus OC43 Infection of Neuronal Cells by Modulation of HLA Class I Expression. Immunological Investigations. 24(6). 977–986. 15 indexed citations
9.
Collins, Arlene R.. (1994). Virus-Ligand Interactions of OC43 Coronavirus with Cell Membranes. Advances in experimental medicine and biology. 342. 285–291. 3 indexed citations
10.
Collins, Arlene R.. (1994). Human Coronavirus OC43 Interacts with Major Histocompatibility Complex Class I Molecules at the Cell Surface to Establish Infection. Immunological Investigations. 23(4-5). 313–321. 20 indexed citations
11.
Collins, Arlene R.. (1993). HLA Class I Antigen Serves as a Receptor for Human Coronavirus OC43. Immunological Investigations. 22(2). 95–103. 46 indexed citations
12.
Collins, Arlene R. & Ole Gade Sørensen. (1986). Regulation of viral persistence in human glioblastoma and rhabdomyosarcoma cells infected with coronavirus OC43. Microbial Pathogenesis. 1(6). 573–582. 17 indexed citations
13.
Collins, Arlene R., Robert L. Knobler, Harry Powell, & Michael J. Buchmeier. (1982). Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell-cell fusion. Virology. 119(2). 358–371. 263 indexed citations
14.
Collins, Arlene R. & Thomas D. Flanagan. (1978). Recovery of a Sendai virus variant with temperature-sensitive hemolytic activity from persistently infected cells from mouse brain. Archives of Virology. 58(2). 81–93. 1 indexed citations
15.
Collins, Arlene R. & Thomas D. Flanagan. (1977). Interferon production and response to exogenous interferon in two cell lines of mouse brain origin persistently infected with Sendai virus. Archives of Virology. 53(4). 313–321. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026